Remove 2001 Remove Governance Remove Licensing
article thumbnail

The Proposed TRIPS Compromise Risks Setting Several Bad Precedents

Bill of Health

Such obligations are unnecessary when a government is keen to acquire vaccines that are both affordable and scarce, and when the vaccine manufacturer has the ability to enforce intellectual property rights, if any, in importing countries. The new obligations for listing of patents were not included in the original TRIPS for good reason.

COVID-19 363
article thumbnail

Managing Healthcare Compliance in West Virginia

MedTrainer

State-specific governing bodies, such as the West Virginia Department of Health and Human Resources (DHHR) and the Bureau for Medical Services (BMS) , oversee and enforce these regulations. West Virginia has distinct regulations and requirements that healthcare providers and organizations must follow.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Proposes Minimum Staffing Requirements and Enhanced Facility Assessments for Nursing Homes

C&M Health Law

The proposed rule represents the first time the federal government has proposed comprehensive nationwide nursing home staffing requirements, although various states have already enacted their own staffing requirements. The 2001 recommendation of 4.1 HPRD from licensed practical nurses, and 2.38 Proposed Staffing Standard – 3.0

article thumbnail

How the Fifty States View Electronic Data as a “Product”

Drug & Device Law

Since digital files were not “articles” under the statute, the government could not rely on this statute to prevent their importation. 2001); Isham v. 2001), relied on these other statutes to hold that a road could not be a “product”). 2001) (applying Illinois law); Serpico v. at 1291-93 (construing 19 U.S.C. at 1291-92.

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Without an FDA license to produce another design, [defendant] was legally prohibited from distributing either [alternative design advocated by plaintiffs] at the time [plaintiff] received her vaccinations. 151, 163-68 (2001)) (lengthy discussion of FDA regulatory process omitted). Wyeth Laboratories, Inc. , 2d 397 (6th Cir.

FDA 59